Alyssa Levin
Finanzdirektor/CFO bei NKARTA, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Alyssa Levin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NKARTA, INC. | Finanzdirektor/CFO | 05.07.2023 | - |
Karriereverlauf von Alyssa Levin
Ehemalige bekannte Positionen von Alyssa Levin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Finanzdirektor/CFO | - | 05.07.2023 |
Ausbildung von Alyssa Levin
University of British Columbia | Undergraduate Degree |
Edwards School of Business | Graduate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Kanada | 3 |
Operativ
Director of Finance/CFO | 2 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NKARTA, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Alyssa Levin
- Erfahrung